IL-33 promotes anemia during chronic inflammation by inhibiting differentiation of erythroid progenitors

An important comorbidity of chronic inflammation is anemia, which may be related to dysregulated activity of hematopoietic stem and progenitor cells (HSPCs) in the bone marrow (BM). Among HSPCs, we found that the receptor for IL-33, ST2, is expressed preferentially and highly on erythroid progenitor...

Full description

Bibliographic Details
Main Authors: Swann, JW, Koneva, LA, Regan-Komito, D, Sansom, SN, Powrie, F, Griseri, T
Format: Journal article
Language:English
Published: Rockefeller University Press 2020
_version_ 1826294030227472384
author Swann, JW
Koneva, LA
Regan-Komito, D
Sansom, SN
Powrie, F
Griseri, T
author_facet Swann, JW
Koneva, LA
Regan-Komito, D
Sansom, SN
Powrie, F
Griseri, T
author_sort Swann, JW
collection OXFORD
description An important comorbidity of chronic inflammation is anemia, which may be related to dysregulated activity of hematopoietic stem and progenitor cells (HSPCs) in the bone marrow (BM). Among HSPCs, we found that the receptor for IL-33, ST2, is expressed preferentially and highly on erythroid progenitors. Induction of inflammatory spondyloarthritis in mice increased IL-33 in BM plasma, and IL-33 was required for inflammation-dependent suppression of erythropoiesis in BM. Conversely, administration of IL-33 in healthy mice suppressed erythropoiesis, decreased hemoglobin expression, and caused anemia. Using purified erythroid progenitors in vitro, we show that IL-33 directly inhibited terminal maturation. This effect was dependent on NF-κB activation and associated with altered signaling events downstream of the erythropoietin receptor. Accordingly, IL-33 also suppressed erythropoietin-accelerated erythropoiesis in vivo. These results reveal a role for IL-33 in pathogenesis of anemia during inflammatory disease and define a new target for its treatment.
first_indexed 2024-03-07T03:39:20Z
format Journal article
id oxford-uuid:bd585791-95d9-4f63-a872-4aa061b8ad1c
institution University of Oxford
language English
last_indexed 2024-03-07T03:39:20Z
publishDate 2020
publisher Rockefeller University Press
record_format dspace
spelling oxford-uuid:bd585791-95d9-4f63-a872-4aa061b8ad1c2022-03-27T05:31:13ZIL-33 promotes anemia during chronic inflammation by inhibiting differentiation of erythroid progenitorsJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:bd585791-95d9-4f63-a872-4aa061b8ad1cEnglishSymplectic ElementsRockefeller University Press2020Swann, JWKoneva, LARegan-Komito, DSansom, SNPowrie, FGriseri, TAn important comorbidity of chronic inflammation is anemia, which may be related to dysregulated activity of hematopoietic stem and progenitor cells (HSPCs) in the bone marrow (BM). Among HSPCs, we found that the receptor for IL-33, ST2, is expressed preferentially and highly on erythroid progenitors. Induction of inflammatory spondyloarthritis in mice increased IL-33 in BM plasma, and IL-33 was required for inflammation-dependent suppression of erythropoiesis in BM. Conversely, administration of IL-33 in healthy mice suppressed erythropoiesis, decreased hemoglobin expression, and caused anemia. Using purified erythroid progenitors in vitro, we show that IL-33 directly inhibited terminal maturation. This effect was dependent on NF-κB activation and associated with altered signaling events downstream of the erythropoietin receptor. Accordingly, IL-33 also suppressed erythropoietin-accelerated erythropoiesis in vivo. These results reveal a role for IL-33 in pathogenesis of anemia during inflammatory disease and define a new target for its treatment.
spellingShingle Swann, JW
Koneva, LA
Regan-Komito, D
Sansom, SN
Powrie, F
Griseri, T
IL-33 promotes anemia during chronic inflammation by inhibiting differentiation of erythroid progenitors
title IL-33 promotes anemia during chronic inflammation by inhibiting differentiation of erythroid progenitors
title_full IL-33 promotes anemia during chronic inflammation by inhibiting differentiation of erythroid progenitors
title_fullStr IL-33 promotes anemia during chronic inflammation by inhibiting differentiation of erythroid progenitors
title_full_unstemmed IL-33 promotes anemia during chronic inflammation by inhibiting differentiation of erythroid progenitors
title_short IL-33 promotes anemia during chronic inflammation by inhibiting differentiation of erythroid progenitors
title_sort il 33 promotes anemia during chronic inflammation by inhibiting differentiation of erythroid progenitors
work_keys_str_mv AT swannjw il33promotesanemiaduringchronicinflammationbyinhibitingdifferentiationoferythroidprogenitors
AT konevala il33promotesanemiaduringchronicinflammationbyinhibitingdifferentiationoferythroidprogenitors
AT regankomitod il33promotesanemiaduringchronicinflammationbyinhibitingdifferentiationoferythroidprogenitors
AT sansomsn il33promotesanemiaduringchronicinflammationbyinhibitingdifferentiationoferythroidprogenitors
AT powrief il33promotesanemiaduringchronicinflammationbyinhibitingdifferentiationoferythroidprogenitors
AT griserit il33promotesanemiaduringchronicinflammationbyinhibitingdifferentiationoferythroidprogenitors